Peptide & Oligo CDMO Services
Research Peptides
CPC Scientific is one of the premier custom peptide producers in the world and we are proud to offer consistently reliable, high-quality peptides directly to researchers.
GMP Peptides
Large-scale manufacturing capacity to support your GMP projects at every stage, from early discovery and late-phase development to full commercialization.
Oligonucleotides
We provide research-grade and clinical-grade oligonucleotide manufacturing services to our clients spanning from discovery to clinical phases.
Peptide-Oligo Conjugates
Our peptide-oligonucleotide conjugate (POC) services seamlessly integrate our peptide and oligonucleotide platforms.
Featured News & Articles
Warm Congratulations to MEDTIDE INC. on its successful listing on the Hong Kong Stock Exchange!
June 30th, 2025|Featured Press Releases|
We are celebrating the successful listing of CPC Scientific’s parent company, MEDTIDE INC. on the Hong Kong Stock Exchange! MEDTIDE INC. announced today that its shares have officially commenced trading on the Main Board of The Stock Exchange of Hong Kong Limited under the stock code 03880. The successful listing marks a significant milestone in the Company’s global pharmaceutical development journey.
White Papers
Mar 23, 2026
Mar 23, 2026
Explore this case study on how our SPPS process optimizations have enabled multi-kilo delivery of a pharmaceutically relevant decapeptide within a challenging timescale, while improving environmental impact and production costs...
Highlights from 2025
Dec 17, 2025
Dec 17, 2025
From our group's IPO milestone to CDMO thought leadership, 2025 marked meaningful progress at CPC Scientific. Explore featured resources from the year and see how our people, partners, and platforms drove impact throughout 2025.
Company News
Dec 15, 2025
Dec 15, 2025
President Theresa Cheng spoke to PhD students at Weill Cornell Graduate School, sharing industry insights and exploring how academic research today can translate into tomorrow’s cutting-edge healthcare leadership...
White Papers
Nov 28, 2025
Nov 28, 2025
This white paper demonstrates how targeted green chemistry practices can be successfully integrated into large-scale SPPS. Our team has developed an innovative DMF recycling strategy that improves process sustainability and cost efficiency...
Press Releases
Nov 24, 2025
Nov 24, 2025
Construction begins on CPC Scientific’s 41,000 sq ft building in Rocklin to establish a new Center of Excellence for Peptide Manufacturing.
Articles & News
Nov 7, 2025
Nov 7, 2025
From Nusinersen to Inclisiran, oligonucleotide APIs are rapidly reshaping modern drug development. Explore the role of oligonucleotide CDMOs in enabling analytical innovation and scalable, compliant manufacturing across the RNA therapeutic frontier.
White Papers
Mar 23, 2026
Mar 23, 2026
Explore this case study on how our SPPS process optimizations have enabled multi-kilo delivery of a pharmaceutically relevant decapeptide within a challenging timescale, while improving environmental impact and production costs...
Highlights from 2025
Dec 17, 2025
Dec 17, 2025
From our group's IPO milestone to CDMO thought leadership, 2025 marked meaningful progress at CPC Scientific. Explore featured resources from the year and see how our people, partners, and platforms drove impact throughout 2025.
Company News
Dec 15, 2025
Dec 15, 2025
President Theresa Cheng spoke to PhD students at Weill Cornell Graduate School, sharing industry insights and exploring how academic research today can translate into tomorrow’s cutting-edge healthcare leadership...
White Papers
Nov 28, 2025
Nov 28, 2025
This white paper demonstrates how targeted green chemistry practices can be successfully integrated into large-scale SPPS. Our team has developed an innovative DMF recycling strategy that improves process sustainability and cost efficiency...
Press Releases
Nov 24, 2025
Nov 24, 2025
Construction begins on CPC Scientific’s 41,000 sq ft building in Rocklin to establish a new Center of Excellence for Peptide Manufacturing.
Articles & News
Nov 7, 2025
Nov 7, 2025
From Nusinersen to Inclisiran, oligonucleotide APIs are rapidly reshaping modern drug development. Explore the role of oligonucleotide CDMOs in enabling analytical innovation and scalable, compliant manufacturing across the RNA therapeutic frontier.
Upcoming Events
Yokohama, Japan | October 7-9, 2026
Launched in 1986, BioJapan is Asia's premier bio-industry partnering event. As the world’s longest-running biotech exhibition, BioJapan continues to drive innovation and collaboration in the industry through its comprehensive event ecosystem, seminars, and partnering programs.
White Papers

This white paper demonstrates how targeted green chemistry practices can be successfully integrated into large-scale SPPS. Our team has developed an innovative DMF recycling strategy that improves process sustainability and cost efficiency...
Mass spectroscopy-based techniques have evolved as a powerful tool in proteomics. Stable isotope-labeled peptides (SIL peptides) are chemically and physically indistinguishable from their endogenous counterparts with respect to retention time, ionization efficiency, and fragmentation pathways.

This white paper explores the click cyclization of RP-182, a promising cancer immunotherapy candidate. Our innovative approach showcases the use of copper catalysis to increase the macrocyclization efficiency of longer peptides under green reaction conditions.
As a rapidly emerging class of next-generation drugs, stapled peptides are expected to combine the synthetic manipulability and cell-penetrating ability of small molecules with the three-dimensionality and versatile target recognition ability of biologics.

In this case study, we demonstrate the synthesis of a Goserelin peptide API impurity through a convergent peptide fragment strategy, expanding our approach to include the unprotected side chains of histidine, tryptophan, and arginine...

Explore this case study on how our SPPS process optimizations have enabled multi-kilo delivery of a pharmaceutically relevant decapeptide within a challenging timescale, while improving environmental impact and production costs...
Recent Publications and Citations
Olivia R. Buonarati, Nidia Quillinan, K. Ulrich Bayer. bioRxiv 2025.
tatCN19o. CPC Scientific; Coultrap et al. 2011. N/A (custom peptide).
Published On: July 23rd, 2025Categories: Citations, Other ResearchJ. Zeng, G.W.Z. Loi, E.N. Saipuljumri, M.A. Romero Durán, O. Silva-García, J.M. Perez-Aguilar, V.M. Baizabal-Aguirre, & C.H. Lo. Proc. Natl. Acad. Sci. U.S.A. 2024 121 (14).
FKC (FKCRRWQWRMKK-NH2), rhodamine-conjugated FKC (Rho-FKCRRWQWRMKK-NH2), and IDR (VQRWLIVWRIRK-NH2) peptides were synthesized using solid phase F-moc chemistry by CPC Scientific, Inc. with a purity greater than 95%.
Published On: July 23rd, 2025Categories: Citations, Dye-LabeledNakagawa, Mayumi, Teresa Evans, Milan Bimali, Hannah Coleman, Jasmine Crane, Nadia Darwish, Jennifer L. Faulkner et al. MedRxiv (2025): 2025-01.
The vaccine consisted of four current good manufacturing production-grade synthetic peptides covering the HPV 16 E6 protein [amino acid (aa)1-45, 46-80, 81-115, and 116-158] (CPC Scientific, San Jose, CA [..]
Published On: January 19th, 2025Categories: Citations, GMP Peptide Manufacturing
What Clients Say About Working With CPC Scientific
CPC Scientific has been our trusted provider of high-quality APIs for several years, consistently delivering exceptional reliability, technical expertise, and quality. Their contribution was instrumental in advancing a life-saving therapy. As a European biotech company, we rely on CPC Scientific’s expertise and dedication to support our long-term success.
CEO, Boutique European Biotechnology Company
CPC Scientific has been an essential CDMO partner throughout our peptide development journey, consistently delivering reliable, high-quality peptides. As a small Brazilian biotech focused on specialized disease areas, we value their fairness, transparency, and seamless collaboration. Their support plays a vital role in helping us bring our innovations to life.
Founder & CEO, Mid-Sized Brazilian Biotech Company
CPC Scientific has been an invaluable CRDMO partner in our research. One representative, in particular, has consistently gone above and beyond to ensure our complex peptide orders were delivered on time, ensuring we met key deadlines for PK and efficacy studies. Their exceptional customer service, responsiveness, and industry expertise have made a significant impact on our work. Even as a relatively new client, we’ve felt fully supported. Thank you, CPC Scientific, for your support of academic drug discovery research through outstanding service!
Faculty Member, Drug Discovery Researcher, and Director of R&D, U.S.-Based Academic Institution
CPC Scientific has been our trusted provider of high-quality APIs for several years, consistently delivering exceptional reliability, technical expertise, and quality. Their contribution was instrumental in advancing a life-saving therapy. As a European biotech company, we rely on CPC Scientific’s expertise and dedication to support our long-term success.
CEO, Boutique European Biotechnology Company
CPC Scientific has been an essential CDMO partner throughout our peptide development journey, consistently delivering reliable, high-quality peptides. As a small Brazilian biotech focused on specialized disease areas, we value their fairness, transparency, and seamless collaboration. Their support plays a vital role in helping us bring our innovations to life.
Founder & CEO, Mid-Sized Brazilian Biotech Company
CPC Scientific has been an invaluable CRDMO partner in our research. One representative, in particular, has consistently gone above and beyond to ensure our complex peptide orders were delivered on time, ensuring we met key deadlines for PK and efficacy studies. Their exceptional customer service, responsiveness, and industry expertise have made a significant impact on our work. Even as a relatively new client, we’ve felt fully supported. Thank you, CPC Scientific, for your support of academic drug discovery research through outstanding service!
Faculty Member, Drug Discovery Researcher, and Director of R&D, U.S.-Based Academic Institution



